Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2011
Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients
Nicolas Azzopardi, Thierry Lecomte, David Ternant, et al.
Oncotarget
|
January 8, 2015
Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1
Barbara Jonchère, Alexandra Vétillard, Bertrand Toutain, et al.
American Journal of Clinical Oncology
|
June 7, 2006
Phase I-II study of pegylated liposomal doxorubicin combined with weekly paclitaxel as first-line treatment in patients with metastatic breast cancer
Hugues Bourgeois, Aurélie Ferru, Alain Lortholary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2005
Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer
Michel Ducreux, Marc Ychou, Agnès Laplanche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2024
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma
James Brugarolas, Gregory Obara, Kathryn E Beckermann, et al.
Investigational New Drugs
|
April 22, 2015
Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors
Jennifer R Diamond, Benjamin Wu, Neeraj Agarwal, et al.
Investigational New Drugs
|
July 8, 2018
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors
Michael Carducci, Montaser Shaheen, Ben Markman, et al.
Blood
|
September 13, 2007
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells
Dorothée Duluc, Yves Delneste, Fang Tan, et al.
American Journal of Hematology
|
April 4, 2017
A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia
Hagop M Kantarjian, Michael W Schuster, Nitin Jain, et al.
Seminars in Oncology
|
April 12, 2017
A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification
Michèle Boisdron-Celle, Jean Philippe Metges, Olivier Capitain, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2011
Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients
Nicolas Azzopardi, Thierry Lecomte, David Ternant, et al.
Oncotarget
|
January 8, 2015
Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1
Barbara Jonchère, Alexandra Vétillard, Bertrand Toutain, et al.
American Journal of Clinical Oncology
|
June 7, 2006
Phase I-II study of pegylated liposomal doxorubicin combined with weekly paclitaxel as first-line treatment in patients with metastatic breast cancer
Hugues Bourgeois, Aurélie Ferru, Alain Lortholary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2005
Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer
Michel Ducreux, Marc Ychou, Agnès Laplanche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2024
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma
James Brugarolas, Gregory Obara, Kathryn E Beckermann, et al.
Investigational New Drugs
|
April 22, 2015
Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors
Jennifer R Diamond, Benjamin Wu, Neeraj Agarwal, et al.
Investigational New Drugs
|
July 8, 2018
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors
Michael Carducci, Montaser Shaheen, Ben Markman, et al.
Blood
|
September 13, 2007
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells
Dorothée Duluc, Yves Delneste, Fang Tan, et al.
American Journal of Hematology
|
April 4, 2017
A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia
Hagop M Kantarjian, Michael W Schuster, Nitin Jain, et al.
Seminars in Oncology
|
April 12, 2017
A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification
Michèle Boisdron-Celle, Jean Philippe Metges, Olivier Capitain, et al.
Page
of 5